Xu Quanyun A, Trissel Lawrence A
Division of Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
Int J Pharm Compd. 2003 Mar-Apr;7(2):149-51.
The physical and chemical stability of clindamycin phosphate 600mg/100mL and 1.2g/100mL admixed in 0.9% sodium chloride injection packaged in AutoDose Infusion System Bags was evaluated. Triplicate test samples were prepared by bringing the required amount of clindamycin phosphate injection to volume with 0.9% sodium chloride injection. A total of 100 mL of each of the test solutions was packaged in each of three ethylene vinyl acetate AutoDose bags designed for use in the AutoDose Infusion System. Samples were stored protected from light and were evaluated at appropriate intervals for up to 30 days at 4 deg C and up to 7 days at 23 deg C. Physical stability was assessed using a multistep evaluation procedure that included both turbidimetric and particulate measurement, as well as visual inspection. Chemical stability was assessed initially and at appropriate intervals during the study periods with stability-indicating high-performance liquid chromatographic anyalytical techinique based on the determination of drug concentrations. Throughout the study, the admixtures were clear and colorless when viewed in normal fluorescent room light and with a Tyndall beam. Measured turbidity and particulate content were low initially and exhibited little change throughout the study. The clindamycin phosphate samples exhibited no increase in measured particulates during the study period. High-performance liquid chromatographic analysis found little or no decomposition in the samples, and the analysis indicated that clindamycin phosphate in the test admixtures remained stable for 30 days at 4 deg C and for 7 days at 23 deg C. The clindamycin phosphate admixtures exhibited physical and chemical stability consistent with previous studies. The AutoDose Infusion System bags were not found to have an adverse effect on the physical and chemical stability of this drug.
评估了包装在自动给药输液系统袋中的600mg/100mL和1.2g/100mL磷酸克林霉素与0.9%氯化钠注射液混合后的物理和化学稳定性。通过用0.9%氯化钠注射液将所需量的磷酸克林霉素注射液稀释至规定体积来制备一式三份的测试样品。将每种测试溶液100mL分别包装在三个设计用于自动给药输液系统的乙烯-醋酸乙烯酯自动给药袋中。样品避光保存,并在4℃下最多保存30天、在23℃下最多保存7天的适当时间间隔进行评估。使用包括比浊法和微粒测量以及目视检查的多步骤评估程序来评估物理稳定性。在研究期间,最初以及在适当的时间间隔,使用基于药物浓度测定的稳定性指示高效液相色谱分析技术评估化学稳定性。在整个研究过程中,在正常荧光室内光线下和用廷德尔光束观察时,混合物均澄清无色。最初测量的浊度和微粒含量较低,并且在整个研究过程中变化很小。在研究期间,磷酸克林霉素样品的测量微粒没有增加。高效液相色谱分析发现样品中几乎没有或没有分解,并且分析表明测试混合物中的磷酸克林霉素在4℃下30天和在23℃下7天内保持稳定。磷酸克林霉素混合物表现出与先前研究一致的物理和化学稳定性。未发现自动给药输液系统袋对该药物的物理和化学稳定性有不利影响。